IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

IQVIA and Medera have partnered to accelerate cardiac gene therapy development and human-based drug discovery, leveraging IQVIA's clinical trial and regulatory expertise alongside Medera's pioneering gene therapy and engineered human cardiac tissue platforms.

This Wire brief sits within Fusion42's coverage of Biotech.